Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06599476 · ClinicalTrials.gov registry record · NA

Rectal Spacers in Prostate Cancer Patients Undergoing Radiation Therapy

A NA study of Prostate Cancer, sponsored by Advanced Radiation Centers of New York.

Active
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT06599476: Active NA study of Prostate Cancer, sponsored by Advanced Radiation Centers of New York.

NCT06599476 is a NA study of Prostate Cancer that is active but no longer recruiting, run by Advanced Radiation Centers of New York. The registered enrollment target is 150 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06599476, a NA study of Prostate Cancer, is active but no longer recruiting, sponsored by Advanced Radiation Centers of New York.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

This is a prospective clinical study involving up to 150 subjects with localized prostate cancer who are scheduled for radiation treatment with rectal spacer placement. The goal of this clinical trial is to assess the safety and efficacy of perirectal spacers in patients undergoing radiation therapy for the treatment of localized prostate cancer. Study visits: * Screening * Spacer placement * Treatment planning simulation * End of the radiation treatment * 1,3,and 6-months FU visits.

Conditions Studied

Interventions

  • DEVICE BioProtect Balloon Implant™ System

Study Locations (1)

New York

  • Advanced Radiation Centers of New York - New Hyde Park

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2024-05-21
Est. Completion 2025-12
Phase NA

What the Registry Record Tells You About NCT06599476

The ClinicalTrials.gov registry entry for NCT06599476 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (75% lower). The listed sponsor is Advanced Radiation Centers of New York, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which BioProtect Balloon Implant™ System is the first listed.

NCT06599476 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06599476 about?

NCT06599476 is a clinical study titled "Rectal Spacers in Prostate Cancer Patients Undergoing Radiation Therapy". This is a prospective clinical study involving up to 150 subjects with localized prostate cancer who are scheduled for radiation treatment with rectal spacer placement. The goal of this clinical trial is to assess the safety and efficacy of perirectal spacers in patients undergoing radiation therap...

What is the current status of trial NCT06599476?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2024-05-21. Estimated completion is 2025-12.

What conditions does trial NCT06599476 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT06599476?

The interventions under investigation include: BioProtect Balloon Implant™ System (DEVICE).

Who is sponsoring clinical trial NCT06599476?

This trial is sponsored by Advanced Radiation Centers of New York, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06599476 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.